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Differentiation between a malignancy and inflammatory process is still a diagnostic challenge. There is no radiologic criterion to allow definitive diagnosis for both inflammatory carcinoma and benign inflammatory disorders including infectious and noninfectious diseases (e.g. granulomatous mastitis, mastitis/abscess formation and fat necrosis) [1, 2] . Breast edema, enlargement, skin thickening, nipple discharge/retraction, abscess and axillary lymphadenopathy are common and nonspecific findings of all above mentioned benign and malignant inflammatory entities [1] . Because benign and malignant inflammatory conditions may have similar signal characteristics and contrast enhancement patterns, as in our case, malignant mass lesions can be masked by diffuse inflammatory process on magnetic resonance imaging (MRI) [1] . On the other hand, 18-fluorodeoxyglucose positron emission tomography (FDG PET) can depict areas of abnormal uptake with a higher sensitivity and shows the site where biopsy should be taken [3] . FDG PET imaging can be a promising alternative imaging method in the evaluation of inflammatory breast diseases and may obviate extensive use of MRI. Here, we present a woman with a mass suspected for malignancy in right breast and radiologic findings in favor of mastitis. FDG PET determined the correct location and dissemination of breast cancer with superiority to other conventional radiological methods.
Case report
A 35-year old woman presented with the complaints of right breast enlargement and nipple retraction. In addition to them, orange peel appearance (peau d'orange) was seen on physical examination but no focal mass was detected ( Figure 1 ). Conventional imaging methods were planned with suspicion of inflammatory breast cancer (IBC) or invasive breast cancer. Ultrasonography (US) revealed diffuse skin thickening and edema without discrete lesion on the right side consistent with benign mastitis. Several lympadenopathy were also noted on the right axillar region. Mammography (MG) was performed shortly after US and confirmed nipple retraction, diffuse skin thickening and marked trabecular thickening ( Figure 2 ). The breast parenchyma was hyperdense and microcalcification or spicules contoured mass lesion consistent with malignity were not present on MG. One week later MRI was performed in order to depict any malignant focus, by using a dedicated breast coil (Figure 3 ). MRI showed diffuse areas of low signal intensity on T1-weighted ( Figure 3A ) and widespread hyperintense areas on T2-weighted images suggesting edema ( Figure 3B, 3C ). These edematous areas demonstrated marked contrast enhancement ( Figure 3D ). However, no focal abnormal signal changes suggesting malignancy was observed, and time-signal intensity curves did not suggest malignancy. Therefore, MRI findings were primarily considered as infectious or granulomatous mastitis. Excisional 
Discussion
Mastitis is a benign inflammatory disease of the breast which may mimic breast cancer clinically and radiologically. It includes a group of acute and chronic inflammatory situations. Nearly half of the patients had clinical and radiological findings suggesting a malignant tumor. Punch biopsy and histopathologic examination are often necessary to determine a definitive diagnosis [4] .
The pathophysiology of breast cancer presenting as mastitis is unclear. It's possible to have been caused by tumor cells damaging epithelial cells and basement membrane surrounding the ductal lumen. This causes death of ductal tissue and behaves as a source for chronic infection. Another possible explanation may be related to recurrent infection of the necrotic areas within the tumor. Thus, these result atypical manifestation of breast cancer as inflammatory mastitis [5] .
It still remains a challenge to differentiate IBC from benign mastitis as well as from breast cancer since they are often misdiagnosed as in our case. Breast erythema, edema, tenderness, pain, warm breast, peau d'orange and swelling are the most common signs suggesting both benign and malign inflammatory conditions. IBC is a rare entity and constitutes 2.5% of all cases with breast cancer. It is the most aggressive variant of breast cancer and has a very poor prognosis. Skin thickening without a mass is the most common radiographic finding on MG and US for IBC as in our case. MRI plays a crucial role in the differential diagnosis of IBC. Tumor emboli blocking the dermal lymphatics are the pathognomonic features on histology which leads to diagnosis [6] . IBC was excluded by several excisional biopsies in our case.
MG and USG provide benefits in many cases for the detection of breast masses and the diagnosis of malignancy. Malign breast lesions tend to appear on MG as micro calcification (76%), soft tissue densities (11%) or both (13%) [4] . However, both of them have low sensitivity and specificity in dense breasts as in our case, and also in patients having a prosthesis or prior surgery. Additionally, it is not uncommon to experience difficulty in differentiation inflammatory breast diseases and breast cancer using US and MG since both could have false negative findings [7] .
Since MRI is highly sensitive in detecting breast cancer, it is often used as a diagnostic tool to evaluate equivocal mammographic findings. Although, MRI cannot replace to MG or US for a complete diagnostic evaluation due to its high cost and limited specificity [8] , it may play an important role in differentiation breast tumor form IBC. Skin enhancement without a mass-like formation, diffuse cutaneous /subcutaneous/ prepectoral edema and skin thickening are the most important findings for IBC in MRI in most cases. Unfortunately, since FDG is not a tumor specific agent, infectious or inflammatory mastitis may also cause false positive FDG uptake for malignancy [5, 12] .
Mastitis is a well-known pitfall for FDG PET, and several cases of increased FDG uptake in acute and chronic infectious mastitis were previously reported [13] . The use of dualtime-point imaging would add to diagnostic accuracy, especially for lesions with lower SUVs and in differentiating inflammation from malignant lesions [12] . However, it's quite possible to differentiate inflammation from breast cancer by visual interpretation, careful clinical history and radiologic correlation.
FDG PET can be used as complementary to conventional radiological imaging techniques especially in equivocal cases or in the presence of negative radiologic findings in patients with a high clinical probability of malignancy. Additionally, FDG PET is a valuable imaging technique to show the extent of the disease regarding nodal status or distant metastases for initial staging in patients with IBC since the probability of metastases is high at presentation [13] .
Conclusion
FDG PET imaging may show encouraging contribution to conventional radiological methods with regard to primary tumor diagnosis, determination of the biopsy site, and also disease staging especially in patients with accompanying inflammatory breast disease.
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